Abstract: A displaying apparatus includes a pixel unit. The pixel unit includes at least one pixel having a light emitting device and a light conversion layer for converting a first wavelength of light of the light emitting device into a second wavelength of light different from the first wavelength; and an insulation layer covers side surfaces of the light emitting device and the light conversion layer.

Abstract: The present disclosure relates to an early cancer diagnosis method and a diagnostic kit using interferon gamma gene concentration measurement in exosomes. By using the interferon gamma gene in exosomes according to the present disclosure, it is possible to early diagnose cancer with high accuracy by a non-invasive method using a liquid biopsy such as blood. In addition, according to the present disclosure, it is possible to supplement the problems of existing tests by quickly and accurately screening and detecting high-risk groups of cancer by a non-invasive method.

Abstract: The present invention is suitable for optical applications with excellent transparency through a haze value of 1.5% or lower and particles that are hardly visible to the naked eye, by producing a film using particles having little difference in refractive index in polyethylene terephthalate (PET), which is a commonly-used polyester film, and can provide a highly transparent optical film capable of improving a winding property by forming surface roughness of 4 nm or higher.

Abstract: The present invention is suitable for optical applications with excellent transparency through a haze value of 1.5% or lower and particles that are hardly visible to the naked eye, by producing a film using particles having little difference in refractive index in polyethylene terephthalate (PET), which is a commonly-used polyester film, and can provide a highly transparent optical film capable of improving a winding property by forming surface roughness of 4 nm or higher.

Abstract: According to the present disclosure, a cancer gene analysis method comprises performing multiplex polymerase chain reaction (MPCR) on a nucleic acid sample extracted from a biological sample using a cancer gene-specific primer set including four or more species of sequences selected from the group consisting of sequence numbers 1 to 72, performing multiplex real-time polymerase chain reaction (MRTPCR) on a product of the MPCR using the primer set and a marker, and identifying the type of the cancer gene using a product of the MRTPCR. The primer set includes an oligonucleotide of a dumbbell structure represented in the following formula: 5?-Ap-Bq-Cr-3?.

Abstract: The present invention relates to a dumbbell-structure oligonucleotide (DSO), a nucleic acid amplification primer comprising the same, and a nucleic acid amplification method using the same and, more specifically, to a method for multi-gene amplification and single-nucleotide polymorphism analysis using a dumbbell-structure oligonucleotide capable of excluding non-specific amplification products prior to binding to a template in a first cycle in performing a polymerase chain reaction.